2 weeks Incyte’s Late-stage NSCLC Study Meets Primary and Secondary Goals Zacks

INCY’s phase III study, evaluating retifanlimab in combination with platinum-based chemotherapy for the treatment of metastatic non-small cell lung cancer, meets primary and secondary endpoints.

Incyte (INCY)

2 weeks EXEL or INCY: Which Is the Better Value Stock Right Now? Zacks

4 weeks Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report? Zacks

1 month Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More Zacks

1 month Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study Zacks

1 month Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered. Investor's Business Daily

1 month After-hours movers: Super Micro Computer, Bakkt Holdings, Incyte, and more Investing.com

2 months BMRN vs. INCY: Which Stock Is the Better Value Option? Zacks

2 months Incyte (NASDAQ:INCY) Announces Quarterly Earnings Results MarketBeat

2 months Earnings call: Incyte reports robust growth and pipeline progress Investing.com

2 months Incyte (NASDAQ:INCY) Raised to “Buy” at Bank of America MarketBeat

2 months Incyte Breaks Out To 17-Month High As Jakafi Demand Surges Investor's Business Daily

2 months INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales Zacks

2 months Here’s What Key Metrics Tell Us About Incyte (INCY) Q3 Earnings Zacks

2 months Incyte Co. (NASDAQ:INCY) Shares Sold by Mediolanum International Funds Ltd MarketBeat

2 months Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY) MarketBeat

2 months Incyte Gears Up to Report Q3 Earnings: Here’s What You Should Know Zacks

2 months Incyte (INCY) Scheduled to Post Quarterly Earnings on Tuesday MarketBeat

More news +

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.